Details about Christopher Joseph McCabe

Access statistics for papers by Christopher Joseph McCabe.

Last updated 2014-01-13. Update your information in the RePEc Author Service.

Short-id: pmc184

Working Papers

2008

1. The NICE Cost-Effectiveness Threshold: What it is and What that Means
   MPRA Paper, University Library of Munich, Germany View citations (76)

2005

2. A Pilot Study of Value of Information Analysis to Support Research Recommendations for the National Institute for Health and Clinical Excellence
   Working Papers, Centre for Health Economics, University of York View citations (8)

2004

3. Estimating population cardinal health state valuation models from individual ordinal (rank) health state preference data
   MPRA Paper, University Library of Munich, Germany View citations (1)

2003

4. Health state values for the HUI 2 descriptive system: results from a UK survey
   MPRA Paper, University Library of Munich, Germany View citations (2)
   See also Journal Article Health state values for the HUI 2 descriptive system: results from a UK survey, Health Economics, John Wiley & Sons, Ltd. (2005) View citations (23) (2005)

Journal Articles

2013

1. Constructing Indirect Utility Models: Some Observations on the Principles and Practice of Mapping to Obtain Health State Utilities
   PharmacoEconomics, 2013, 31, (8), 635-641 View citations (1)
2. Measuring health outcomes of adolescents: report from a pilot study
   The European Journal of Health Economics, 2013, 14, (1), 11-19 View citations (1)
3. Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help?
   PharmacoEconomics, 2013, 31, (9), 731-737
4. What Evidence Is There for the Reimbursement of Personalised Medicine?
   PharmacoEconomics, 2013, 31, (3), 181-183 View citations (3)

2012

5. Estimating the population utility function: A parametric Bayesian approach
   European Journal of Operational Research, 2012, 218, (2), 538-547 View citations (3)

2007

6. Is there a case for using visual analogue scale valuations in CUA’ by Parkin and Devlin a response: ‘yes there is a case, but what does it add to ordinal data?
   Health Economics, 2007, 16, (6), 645-647 View citations (3)
7. Multi-attribute utility function or statistical inference models: A comparison of health state valuation models using the HUI2 health state classification system
   Journal of Health Economics, 2007, 26, (5), 992-1002 View citations (5)
8. Response to Shmueli
   Health Economics, 2007, 16, (7), 759-761

2006

9. Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion
   Health Economics, 2006, 15, (1), 1-4 View citations (18)
10. Erratum to ‘Health state values for the health utilities index mark 2 descriptive system: results from a UK valuation survey’ Health Economics 2005; 14(3): 231–244
    Health Economics, 2006, 15, (7), 761-761 View citations (1)
11. Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey
    Health Economics, 2006, 15, (5), 527-533 View citations (4)
12. Using rank data to estimate health state utility models
    Journal of Health Economics, 2006, 25, (3), 418-431 View citations (29)
13. Whither trial‐based economic evaluation for health care decision making?
    Health Economics, 2006, 15, (7), 677-687 View citations (44)

2005

14. Health state values for the HUI 2 descriptive system: results from a UK survey
    Health Economics, 2005, 14, (3), 231-244 View citations (23)
    See also Working Paper Health state values for the HUI 2 descriptive system: results from a UK survey, MPRA Paper (2003) View citations (2) (2003)
15. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
    Health Economics, 2005, 14, (4), 339-347 View citations (74)